Using of calcium channel blockers in patients with COVID-19: a magic bullet or a double-edged sword?

Articles in the same Issue

1. Frontmatter
2. Minireviews
3. Characteristics and management of asymptomatic SARS-CoV-2 infections
4. Perspectives into the possible effects of the B.1.1.7 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on spermatogenesis
5. Antibody-dependent enhancement of virus infection and disease: implications in COVID-19
6. Reviews
7. A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19
8. Increase in SARS-CoV-2 infected biomedical waste among low middle-income countries: environmental sustainability and impact with health implications
9. A dossier on COVID-19 chronicle
10. Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility
11. Original Articles
12. COVID-19 infection in children with underlying malignancies in Iran
13. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method
14. COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young males
15. Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India
16. Letter to the Editors
17. The “Delta Plus” COVID-19 variant has evolved to become the next potential variant of concern: mutation history and measures of prevention
18. Can sulfasalazine as an old drug with immunomodulatory and anti‐inflammatory effects be effective in COVID‐19?
19. Using of calcium channel blockers in patients with COVID-19: a magic bullet or a double-edged sword?